Improved hematopoietic stem cell transplantation upon inhibition of natural killer cell-derived interferon-gamma

[1]  S. Crippa,et al.  Mesenchymal Stromal Cells: Role in the BM Niche and in the Support of Hematopoietic Stem Cell Transplantation , 2018, HemaSphere.

[2]  D. Tenen,et al.  C/EBPγ is dispensable for steady-state and emergency granulopoiesis , 2018, Haematologica.

[3]  Y. Hirata,et al.  CD150high Bone Marrow Tregs Maintain Hematopoietic Stem Cell Quiescence and Immune Privilege via Adenosine. , 2018, Cell stem cell.

[4]  M. Nolte,et al.  Memory CD8+ T cells support the maintenance of hematopoietic stem cells in the bone marrow , 2018, Haematologica.

[5]  J. Dick,et al.  Enhanced human hematopoietic stem and progenitor cell engraftment by blocking donor T cell–mediated TNFα signaling , 2017, Science Translational Medicine.

[6]  M. Nolte,et al.  Impact of T cells on hematopoietic stem and progenitor cell function: Good guys or bad guys? , 2017, World Journal of Stem Cells.

[7]  Y. Kfoury,et al.  Hematopoietic Stem Cell Niche in Health and Disease. , 2016, Annual review of pathology.

[8]  W. Murphy,et al.  Mouse host unlicensed NK cells promote donor allogeneic bone marrow engraftment. , 2016, Blood.

[9]  K. Rezvani,et al.  Cord Blood as a Source of Natural Killer Cells , 2016, Front. Med..

[10]  V. Roy,et al.  Dual roles of autologous CD8+ T cells in hematopoietic progenitor cell mobilization and engraftment , 2015, Transfusion.

[11]  A. Fischer,et al.  CD45RA depletion in HLA-mismatched allogeneic hematopoietic stem cell transplantation for primary combined immunodeficiency: A preliminary study. , 2015, The Journal of allergy and clinical immunology.

[12]  E. Pietras,et al.  Pro-inflammatory cytokines: emerging players regulating HSC function in normal and diseased hematopoiesis. , 2014, Experimental cell research.

[13]  C. Schürch,et al.  Cytotoxic CD8+ T cells stimulate hematopoietic progenitors by promoting cytokine release from bone marrow mesenchymal stromal cells. , 2014, Cell stem cell.

[14]  L. Moretta,et al.  Understanding human NK cell differentiation: clues for improving the haploidentical hematopoietic stem cell transplantation. , 2013, Immunology letters.

[15]  C. Di Cresce,et al.  Regional localization within the bone marrow influences the functional capacity of human HSCs. , 2013, Cell stem cell.

[16]  D. Link,et al.  Regulation of Hematopoietic Stem Cell Activity by Inflammation , 2013, Front. Immunol..

[17]  S. Malarkannan,et al.  Clinical Relevance of Natural Killer Cells Following Hematopoietic Stem Cell Transplantation , 2012, Journal of Cancer.

[18]  D. Longo,et al.  Mouse NK cell-mediated rejection of bone marrow allografts exhibits patterns consistent with Ly49 subset licensing. , 2012, Blood.

[19]  K. MacNamara,et al.  Transient Activation of Hematopoietic Stem and Progenitor Cells by IFNγ during Acute Bacterial Infection , 2011, PloS one.

[20]  W. Leung.  Use of NK cell activity in cure by transplant , 2011, British journal of haematology.

[21]  D. Raulet,et al.  Mature natural killer cells reset their responsiveness when exposed to an altered MHC environment , 2010, The Journal of experimental medicine.

[22]  J. Klein,et al.  Decreased infections in recipients of unrelated donor hematopoietic cell transplantation from donors with an activating KIR genotype. , 2010, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

[23]  Nathan C Boles,et al.  Quiescent hematopoietic stem cells are activated by IFNγ in response to chronic infection , 2010, Nature.

[24]  K. Hsu,et al.  Donor activating KIR3DS1 is associated with decreased acute GVHD in unrelated allogeneic hematopoietic stem cell transplantation. , 2010, Blood.

[25]  H. Lodish,et al.  Cytokines regulating hematopoietic stem cell function , 2008, Current opinion in hematology.

[26]  Eric Vivier,et al.  Functions of natural killer cells , 2008, Nature Immunology.

[27]  A. Toubert,et al.  Activating KIR genes are associated with CMV reactivation and survival after non-T-cell depleted HLA-identical sibling bone marrow transplantation for malignant disorders , 2006, Bone Marrow Transplantation.

[28]  K. Anderson,et al.  Cytokines regulate postnatal hematopoietic stem cell expansion: opposing roles of thrombopoietin and LNK. , 2006, Genes & development.

[29]  J. P. Santo.  NATURAL KILLER CELL DEVELOPMENTAL PATHWAYS: A Question of Balance , 2006 .

[30]  J. Wagner,et al.  Effect of graft-versus-host disease prophylaxis on 3-year disease-free survival in recipients of unrelated donor bone marrow (T-cell Depletion Trial): a multi-centre, randomised phase II–III trial , 2005, The Lancet.

[31]  L. Lybarger,et al.  Licensing of natural killer cells by host major histocompatibility complex class I molecules , 2005, Nature.

[32]  S. E. Jacobsen,et al.  IFN-γ Negatively Modulates Self-Renewal of Repopulating Human Hemopoietic Stem Cells1 , 2005, The Journal of Immunology.

[33]  A. Gratwohl,et al.  Purified donor NK-lymphocyte infusion to consolidate engraftment after haploidentical stem cell transplantation , 2004, Leukemia.

[34]  P. Parham,et al.  Alloreactive killer cells: hindrance and help for haematopoietic transplants , 2003, Nature Reviews Immunology.

[35]  D. Longo,et al.  Increased bone marrow allograft rejection by depletion of NK cells expressing inhibitory Ly49 NK receptors for donor class I antigens. , 2002, Blood.

[36]  Katia Perruccio,et al.  Effectiveness of Donor Natural Killer Cell Alloreactivity in Mismatched Hematopoietic Transplants , 2002, Science.

[37]  S. Akira,et al.  Impairment of Natural Killer Cytotoxic Activity and Interferon γ Production in Ccaat/Enhancer Binding Protein γ–Deficient Mice , 1999, The Journal of experimental medicine.

[38]  K. Sullivan,et al.  Infectious morbidity in long‐term survivors of allogeneic marrow transplantation is associated with low CD4 T cell counts , 1997, American journal of hematology.

[39]  D. Longo,et al.  Interleukin-2-activated natural killer cells can support hematopoiesis in vitro and promote marrow engraftment in vivo. , 1992, Blood.

[40]  C. Pui,et al.  Rapid memory T-cell reconstitution recapitulating CD45RA-depleted haploidentical transplant graft content in patients with hematologic malignancies , 2015, Bone Marrow Transplantation.

[41]  Emmes.  Effect of graft-versus-host disease prophylaxis on 3-year disease-free survival in recipients of unrelated donor bone marrow (T-cell Depletion Trial): a multi-centre, randomised phase II-III trial , 2005 .